Evidence map›Paper›PMID 41528708›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

An In Vitro Ubiquitination Assay to Study Phytoplasmal Effector Function.

Margot Raffeiner

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Margot RaffeinerFaculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany. margot.raffeiner@rub.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The attachment of one or more ubiquitin molecules onto a target substrate, ubiquitination for short, is a posttranslational modification that determines its correct further processing within a eukaryotic cell. Ubiquitination was shown to be a central player in the regulation of many cellular processes from protein degradation to protein sorting (e.g., endocytosis), DNA repair, or other non-proteolytic pathways. Because of its importance in maintaining cellular homeostasis, it is not surprising that, in the course of evolution, pathogens, including plant pathogens such as phytoplasma, have developed strategies to manipulate ubiquitination of host targets to their own benefit. Manipulation includes the translocation of so-called effector proteins that themselves ubiquitinate host targets, thereby mediating their subsequent degradation to dampen host immune responses.The identification and characterization of phytoplasmal effector proteins that ubiquitinate target substrates, as well as the detection of a target ubiquitination is crucial to understand phytoplasma-associated pathogenesis.Here, we provide an easy-to-follow protocol adapted from a method described by Furlan and Trujillo (2017) to study the in vitro E3 ligase activity potential of phytoplasma effector proteins. Additionally, this protocol allows to study the in vitro ubiquitination of putative target substrates by phytoplasma effectors.

Indexed as

Bacterial ProteinsPhytoplasmaUbiquitinationHost-Pathogen InteractionsProtein Processing, Post-TranslationalUbiquitinUbiquitin-Protein LigasesBacterial ProteinsUbiquitinUbiquitin-Protein LigasesEffector proteinsEffector targetsIn vitro ubiquitinationPhytoplasmaPosttranslational modificationUbiquitin

Identifiers

PMID41528708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.